U.S. Must Fast-track COVID Tech Sharing, says AHF

The announcement comes after the U.S. backed a similar proposal in June covering COVID-19 vaccine know-how.

Metadata
Provider: 
Business Wire, Inc.Business Wire, Inc.
Retrieved on: 
Wednesday, December 7, 2022
Information
Tags: 
Advocacy Group Opinion, Other Health, White House, Federal Government, Pharmaceutical, Public Policy, Other Policy Issues, Infectious Diseases, Social Activism, Foundation, Philanthropy, Congressional News, Views, Public Policy, Government, General Health, Biotechnology, AIDS, Health, COVID-19, Communications, Health Technology, Lifting, Therapy, USTR, VOW, World Trade Organization, Pandemic, Big Pharma, AIDS Healthcare Foundation, Government, AHF, COVID-19, Vaccine, COVID-19 vaccine, Patent, Pharmaceutical industry
Geotags: 
NORTH AMERICA, UNITED STATES, EUROPE, BELGIUM, LUXEMBOURG, CALIFORNIA, SOUTH AFRICA, INDIA, AFRICA
⚠ generated by AI ↴
Organisation: 
AIDS HEALTHCARE FOUNDATION, AIDS HEALTHCARE FOUNDATION (AHF)
Summary
Key Points: 
  • The announcement comes after the U.S. backed a similar proposal in June covering COVID-19 vaccine know-how.
  • During pandemics and international outbreaks, global health security must unequivocally take precedence over corporate profits.
  • We are currently the largest non-profit provider of HIV/AIDS medical care in the world.
  • To learn more about AHF, please visit our website: www.aidshealth.org , find us on Facebook: www.facebook.com/aidshealth and follow us on Twitter: @aidshealthcare and Instagram: @aidshealthcare
    View source version on businesswire.com: https://www.businesswire.com/news/home/20221206006090/en/


AIDS Healthcare Foundation (AHF) is disappointed that the U.S. Trade Representative (USTR) has put the brakes on the international negotiations that sought to expand access to COVID-19 diagnostics and treatments by lifting patent protections in developing countries.

The World Trade Organization (WTO) was set to decide on the patent waiver by Dec. 17, but now the USTR says the U.S. government will not back the initiative until it has time to study its impact. The announcement comes after the U.S. backed a similar proposal in June covering COVID-19 vaccine know-how.

“Unlike vaccines, which require bespoke proteins and must be grown in a lab, tests and treatments can be more easily reverse engineered if generic manufacturers have the blueprint—that’s why Big Pharma is leveraging its considerable lobbying power to stall the WTO patent waiver this time around,” said AHF President Michael Weinstein. “During pandemics and international outbreaks, global health security must unequivocally take precedence over corporate profits. We urge the USTR to expedite the review of the WTO proposal and endorse it in line with the earlier decision on the vaccines – with the resurgence of COVID-19, millions of lives depend on it.”

AHF has strongly supported the emergency waiver of patents on COVID-19 vaccines, diagnostics, and therapeutics through its Vaccinate Our World (VOW) campaign since India and South Africa first introduced the idea at the World Trade Organization in 2020. Learn more about the VOW campaign here.

About AIDS Healthcare Foundation (AHF)

AIDS Healthcare Foundation (AHF) is a global non-profit organization providing cutting-edge medicine and advocacy to over 1.6 million people in 45 countries worldwide in the US, Africa, Latin America/Caribbean, the Asia/Pacific Region and Europe. We are currently the largest non-profit provider of HIV/AIDS medical care in the world. To learn more about AHF, please visit our website: www.aidshealth.org, find us on Facebook: www.facebook.com/aidshealth and follow us on Twitter: @aidshealthcare and Instagram: @aidshealthcare

Copyright: 
Copyright Business Wire 2022